DARE: Dare Bioscience Market Cap to Revenue Ratio

Symbol and logo of brand Daré Bioscience, Inc. (DARE)

Financial pressure stemming from the costs of bringing new drugs to market and early-stage development creates risks for Dare Bioscience, Inc. (DARE). However, an intellectual property licensing model tailored for pharma behemoths ensures high profit scalability. Dare Bioscience, Inc. (DARE) focuses on the B2C gynecological segment by developing local medications. The P/S ratio dynamics help avoid overpaying for the asset, with the indicator currently reaching 9.30.

Price-to-Revenue Ratio: darebioscience.com (DARE) for 08/14/2022 - 11/13/2026

Dare Bioscience Inc. (DARE) - metric breakdowns and financial figures

- stock price and consensus target price:
Share Price darebioscience.com|DARE - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Dare Bioscience Inc.|DARE - Enterprise Value
- business book valuation details:
Book Value per Share Daré Bioscience|DARE - Company Book Value|Market Value to Book Value darebioscience.com|DARE - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Daré Bioscience, Inc.|DARE - Company Aggregate Debts|Debt to Book Capitalization Ratio Dare Bioscience Inc.|DARE - Company Long-Term Debts|Short-Term Debt Volume Daré Bioscience|Immediate Liquidity darebioscience.com
- company profitability and valuation multiples indicators:
DARE - Company Net Income|Company Profit Forecast Dare Bioscience, Inc.|DARE - P/E Multiple|Projected Price to Earnings Dare Bioscience|DARE - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dare Bioscience Inc.|DARE - Operating profit EBITDA|Net earnings per one share for the last twelve months Daré Bioscience|DARE - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months darebioscience.com|DARE - Earnings growth in current year|Expected earnings per share growth for next year Dare Bioscience, Inc.
- total revenue and sales volume data:
DARE - Revenue and Sales Volume|Company Expected Sales Volume darebioscience.com|DARE - Market Cap to Revenue|Forward Price to Sales Dare Bioscience Inc.
General company analysis:darebioscience.com DARE
Mass-produced product of Daré Bioscience, Inc.

The Dare Bioscience, Inc. (DARE) business in women's health is independent of macroeconomic cycles, relying exclusively on the success of clinical trials. The P/S multiple compares current market capitalization to annual revenue, reflecting the value of each unit of sales. This indicator measures market expectations regarding the pace of commercialization of developments and the company's stage of maturity. Analyzing the industry-average P/S of Dare Bioscience, Inc. (DARE) allows for determining whether the asset is in a phase of expansion or stagnation.

Competing companies

organon.com - Market Cap to Revenue Ratio|P/S Multiple TXMD (TherapeuticsMD)|PTN: Market Cap to Revenue Ratio